Generics BulletinHBW InsightIn VivoMedtech InsightPink SheetScrip

Generics Bulletin

Medtech Insight

Pfizer Signals Waning Interest In Biosimilars

Jul 28 2021

• By Jessica Merrill

bored dog — Pfizer suggested it is losing interest in biosimilars • Source: Alamy

Related Content

Organon Completes Spin-Out From Merck With Five Biosimilars

Jun 04 2021

Pfizer And J&J Settle Remicade Antitrust Litigation

Jul 22 2021

Pfizer’s Biosimilar Strategy Might Be Working

Jan 28 2020

Pfizer On Boosters, Kids And Prospects For A Long-Term COVID-19 Business

Jul 28 2021

Related Companies

Pfizer Inc.

AbbVie Inc.

Roche Holding AG

Amgen, Inc.

Johnson & Johnson

Mylan Pharmaceuticals Inc.

Viatris Inc.

Merck & Co., Inc.

Additional Topics

Biosimilars Business Strategies Commercial Companies Sales & Earnings Strategy BioPharmaceutical

More from Strategy

More from Business

Twitter feed RSS feed RSS feed

About UsOpens in new window
Meet the TeamOpens in new window
RSS FeedOpens in new window

Contact Us
Customer Service
Subscribe
AdvertisingOpens in new window
Feedback

Terms and ConditionsOpens in new window

Privacy PolicyOpens in new window